TRAF6 and cervical carcinoma: In other urogenital cancers, such as advanced cervical cancer, DRAK1 suppresses pro-inflammatory signaling by promoting TRAF6 degradation, thereby inhibiting inflammatory signaling-mediated tumor growth and metastasis 125.